Cowen Lowers Stereotaxis (NYSEAMERICAN:STXS) Price Target to $5.00

Stereotaxis (NYSEAMERICAN:STXSGet Rating) had its price objective lowered by Cowen from $7.00 to $5.00 in a research report report published on Friday morning, The Fly reports. The firm currently has an outperform rating on the stock.

Separately, Piper Sandler reduced their target price on shares of Stereotaxis from $8.00 to $6.00 in a research report on Tuesday, August 9th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Stereotaxis has an average rating of Buy and an average target price of $7.83.

Stereotaxis Stock Up 9.3 %

Shares of NYSEAMERICAN STXS opened at $2.00 on Friday. The stock has a market capitalization of $149.58 million, a PE ratio of -8.00 and a beta of 1.63. Stereotaxis has a 52 week low of $1.55 and a 52 week high of $7.22.

Institutional Investors Weigh In On Stereotaxis

A number of hedge funds have recently modified their holdings of STXS. Amalgamated Bank purchased a new position in Stereotaxis during the first quarter worth about $30,000. Everett Harris & Co. CA boosted its stake in Stereotaxis by 66.7% during the third quarter. Everett Harris & Co. CA now owns 25,000 shares of the company’s stock worth $45,000 after buying an additional 10,000 shares during the period. Wellington Shields & Co. LLC purchased a new position in Stereotaxis during the first quarter worth about $58,000. Cherry Creek Investment Advisors Inc. boosted its stake in Stereotaxis by 33.5% during the second quarter. Cherry Creek Investment Advisors Inc. now owns 32,306 shares of the company’s stock worth $59,000 after buying an additional 8,100 shares during the period. Finally, Walleye Capital LLC boosted its stake in Stereotaxis by 103.0% during the second quarter. Walleye Capital LLC now owns 44,204 shares of the company’s stock worth $81,000 after buying an additional 22,427 shares during the period. Hedge funds and other institutional investors own 48.74% of the company’s stock.

Stereotaxis Company Profile

(Get Rating)

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.

See Also

The Fly logo

Analyst Recommendations for Stereotaxis (NYSEAMERICAN:STXS)

Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.